Covidien launches minimally invasive surgical products in Europe

11 April 2008

Covidien (NYSE: COV, BSX: COV) has announced that its Surgical Devices business unit has launched three new surgical access products in Europe, the VersaStep Plus 15mm, Visiport Plus with fixation and Versaport Plus RPF 15mm with fixation.

The VersaStep Plus 15mm is an innovative bladeless laparoscopic access system with a radially expandable sleeve that minimizes the fascial defect and reduces the downward insertion forces associated with normal trocar insertion. It uses the company's proprietary Proven Step technology that is designed to enhance patient safety, save time in surgery and reduce the likelihood of complications, including vascular and visceral injuries.

The Visiport Plus with fixation supplies a Versaport Plus fixation cannula, an enhanced cannula with integrated fixation ribs for excellent port stability, and a Visiport Plus optical trocar that provides direct visualization of tissue layers during primary port insertion and allows a combination of controlled blunt and sharp dissection during entry.

The Versaport Plus RPF 15mm with fixation is used in advanced laparoscopic procedures as it accommodates larger instrumentation. The Versaport Plus RPF 15mm is also now supplied with an enhanced cannula with integrated fixation ribs for excellent port stability.

To top